RESUMEN
INTRODUCTION: Percutaneous endoscopic gastrostomy (PEG) is considered a safe and effective method for nutritional support in patients with malnutrition and swallowing impairment with an estimated survival of over two months. Some indications, such as advanced cognitive decline, contraindicate the technique. MATERIALS AND METHODS: All patients who underwent PEG placement between January 2001 and May 2019 were included. Clinical data, indication, complications, and mortality were retrospectively analyzed. RESULTS: A total of 648 patients (46.5% male, mean age 70±18.5 years) were included. The most common indications for PEG were advanced cognitive decline (31.5%) and cerebrovascular disease (18.8%). The mean follow-up was 12.07 months (IQR 3.27-34.73). 39.5% of patients experienced complications (systemic 17.9%, local 28.5%). The most frequent were bronchoaspiration (9.7%) and rupture/dysfunction (13.9%), respectively. The presence of early complications (HR 1.63 [1.20-2.21]) and age (HR 1.02 [1.01-1.02]) were associated with shorter survival time, while female sex was a protective factor (HR 0.78 [0.66-0.94]). CONCLUSIONS: PEG is not without complications, with 39.5% of patients experiencing them. Patients with advanced dementia, male sex, older age, and systemic complications have lower survival following PEG placement.
RESUMEN
We present the case of a 38-year-old man with no previous medical history who went to the emergency department due to abdominal pain and diarrheal stools with blood of 24 hours of evolution. The patient reports consumption of anti-inflammatories the previous days due to back pain.
Asunto(s)
Colitis Isquémica , Colitis , Dolor Abdominal/inducido químicamente , Adulto , Antiinflamatorios no Esteroideos/efectos adversos , Colitis/inducido químicamente , Colitis Isquémica/inducido químicamente , Colitis Isquémica/diagnóstico por imagen , Diarrea/inducido químicamente , Humanos , MasculinoRESUMEN
No disponible
Asunto(s)
Humanos , Masculino , Adulto , Hemorragia Gastrointestinal/inducido químicamente , Inhibidores Selectivos de la Recaptación de Serotonina/administración & dosificación , Antiinflamatorios no Esteroideos/administración & dosificación , Gastroscopía/métodos , Úlcera Duodenal/diagnóstico por imagen , Hemorragia Gastrointestinal/complicaciones , Inhibidores Selectivos de la Recaptación de Serotonina/efectos adversos , Antiinflamatorios no Esteroideos/efectos adversos , Dolor Abdominal/etiología , Úlcera Duodenal/cirugía , Biopsia , Enteroscopia de Balón Individual/métodos , Factores de RiesgoRESUMEN
No disponible
Asunto(s)
Humanos , Masculino , Adulto , Enfermedad de Crohn/diagnóstico , Parasitosis Intestinales/diagnóstico , Absceso Hepático Amebiano/diagnóstico , Antiprotozoarios/uso terapéutico , Colonoscopía , Enfermedad de Crohn/tratamiento farmacológico , Diagnóstico Diferencial , Errores Diagnósticos , Drenaje/métodos , Entamoeba/aislamiento & purificación , Enfermedades Inflamatorias del Intestino/diagnóstico , Parasitosis Intestinales/terapia , Absceso Hepático Amebiano/terapia , Metronidazol/uso terapéutico , Ultrasonografía IntervencionalRESUMEN
No disponible